These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3537545)

  • 1. Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled study.
    Frascà GM; Vangelista A; Raimondi C; Bonomini V
    Life Support Syst; 1986; 4(3):231-7. PubMed ID: 3537545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of defibrotide in renal transplantation in man.
    Bonomini V; Vangelista A; Stefoni S; Scolari MP; Frascà GM; Raimondi C
    Haemostasis; 1986; 16 Suppl 1():48-50. PubMed ID: 3519383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A; Marshall L; Lancaster D
    Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of deep venous thrombosis with defibrotide in chest surgery. Controlled multicenter study versus heparin].
    Rizzi A; Radaelli F; Pisano M; Orro S; Nazzari M; Ratti G; Giobbe R; Maggi G
    Minerva Med; 1987 Jun; 78(11):745-50. PubMed ID: 3295599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy.
    Bonomini V; Frascà GM; Raimondi C; Liviano D'arcangelo G; Vangelista A
    Nephron; 1985; 40(2):195-200. PubMed ID: 3839050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of thromboembolism in patients operated on for hip prosthesis].
    Cremonese M; Rigon N; Ratti G; Pojana A; Todesco A; Sartore A
    Minerva Med; 1988 May; 79(5):367-72. PubMed ID: 3287226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of vena cava thrombosis during catheterization. Comparison of calciheparin and defibrotide].
    Grosso P; Martello L; Petrini PL; Massei R
    Minerva Anestesiol; 1989 Jun; 55(6):273-6. PubMed ID: 2694006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Defibrotide in the prevention of deep venous thrombosis in general surgery. Preliminary results of a multicenter study].
    Ferrari PA; Cornelli U; Dina F; Gerosa C; Nazzari M; Ratti G
    Minerva Med; 1988 Jul; 79(7):551-61. PubMed ID: 3043258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM; White DJ; Thiru S; Evans DB; Calne RY
    N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Defibrotide versus heparin in antithrombotic prophylaxis in gynecological surgery].
    Lippi G; Viliani T; Alessandrello-Liotta A; Morelli P; Zucconi G; Doni A; Gerosa C
    Minerva Med; 1989 May; 80(5):455-9. PubMed ID: 2664571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of plasmapheresis in kidney transplantation--a controlled study].
    Vangelista A; Frascà GM; di Felice A; Liviano d'Arcangelo G; Bonomini V
    Z Urol Nephrol; 1986 Jun; 79(6):311-6. PubMed ID: 3529744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.